Marianne Kavanagh, Ph.D.
About Marianne Kavanagh, Ph.D.
Marianne Kavanagh, Ph.D., is a Senior Project Manager at Asher Biotherapeutics and a Senior Clinical Program Manager at Nuvation Bio, both roles she has held since 2022. She has extensive experience in clinical trial management, a strong background in pharmacology, and is trained in Good Clinical Practice.
Work at Asher Bio
Marianne Kavanagh, Ph.D., has been serving as a Senior Project Manager in the Program Management Organization at Asher Biotherapeutics since 2022. In this role, she oversees project management activities, ensuring that clinical trials are conducted efficiently and in compliance with regulatory standards. Her responsibilities include coordinating cross-functional teams and managing timelines to facilitate successful project outcomes.
Work at Nuvation Bio
In addition to her role at Asher Biotherapeutics, Marianne Kavanagh also works as a Senior Clinical Program Manager at Nuvation Bio since 2022. Here, she is responsible for the management of clinical programs, focusing on the strategic planning and execution of clinical trials. Her expertise in clinical development supports the advancement of innovative therapies.
Education and Expertise
Marianne Kavanagh holds a Doctor of Philosophy in Pharmacology from the University of California, Santa Barbara. She also possesses a Professional Certificate in Clinical Trials Design and Management from San Francisco State University. Her educational background provides a strong foundation for her work in clinical trial management and biomedical writing.
Background
Marianne Kavanagh has a background as a bench scientist, which enhances her technical and analytical skills in clinical development. She is trained in Good Clinical Practice (GCP), ensuring that clinical trials adhere to ethical and scientific quality standards. Her experience spans managing clinical trials across multiple regions, including Europe, Asia, Japan, and Latin America.
Clinical Trial Management Skills
Marianne Kavanagh is skilled in various aspects of clinical trial management, including risk assessment and mitigation. She is proficient in biomedical writing and informed consent form (ICF) development, contributing to the overall quality and compliance of clinical studies. Her proactive approach to trial management supports the successful execution of complex clinical programs.